-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Agilon Health, Lowers Price Target to $5

Benzinga·04/15/2025 12:07:04
Listen to the news
Baird analyst Michael Halloran maintains Agilon Health (NYSE:AGL) with a Neutral and lowers the price target from $6 to $5.